Who invested in Clarus Therapeutics?
Clarus Therapeutics's investors include H.I.G. Capital, Thomas, McNerney & Partners and C-Bridge Capital.
United States · Venture startup
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$40Mraised across 2 rounds since 2007, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Clarus Therapeutics's investors include H.I.G. Capital, Thomas, McNerney & Partners and C-Bridge Capital.
Clarus Therapeutics has raised $40M across 2 rounds since 2007.
Clarus Therapeutics's most recent round was a Venture of $32M in Jun 2014.
Its most recent round, $32M in Jun 2014, is also its largest on record.
Clarus Therapeutics's first round on record, in Nov 2007, was backed by H.I.G. Capital and Thomas, McNerney & Partners.
Clarus Therapeutics's latest named round is a Venture, in Jun 2014.
Clarus Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.